Search clinical trials for: CELIVARONE (SSR149744C)

Total 6 results

Sanofi

Completed

Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (CORYFEE)

Atrial Fibrillation | Atrial Flutter

United States, France, Canada, Germany, Italy, Netherlands, Portugal, Czech Republic, Hungary
Sanofi

Completed

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (MAIA)

Atrial Fibrillation | Atrial Flutter

United States, France, Canada, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Japan, Argentina, Denmark, Hungary, Australia, Chile
Sanofi

Completed

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS (ICARIOS)

Arrhythmia | Ventricular Fibrillation | Tachycardia, Ventricular

United States, Canada, Germany, Italy, Netherlands, Switzerland, Belgium, Czech Republic
Deraya University

Completed

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Female Sexual Dysfunction

Egypt
Sanofi

Completed

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death (ALPHEE)

Ventricular Arrhythmia | Arrhythmia Prophylaxis

Netherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
IVI Madrid

Completed

Gonadotropin Type in Ovarian Stimulation

Infertility

Search clinical trials for: CELIVARONE (SSR149744C)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations